Exact Mass: 368.192
Exact Mass Matches: 368.192
Found 138 metabolites which its exact mass value is equals to given mass value 368.192
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
LysoPA(a-13:0/0:0)
LysoPA(a-13:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(a-13:0/0:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
LysoPA(i-13:0/0:0)
LysoPA(i-13:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-13:0/0:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
N-(4-(4-Methyl-1-piperazinyl)phenyl)-9-acridinamine
(2S,3S,4S,8R,9S,13R,14R,15S,16R)-3,4,8,14,15-pentahydroxy-2,13,16-trimethyl-6-methylidene-10-oxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadecan-11-one
phthalic acid mono-[2-methyl-5-(2-methyl-3-methylene-[2]norbornyl)-pent-2-enyl ester]|Phthalsaeure-mono-[2-methyl-5-(2-methyl-3-methylen-[2]norbornyl)-pent-2-enylester]
2-(4-Methoxyphenyl)-5,7-dimethoxy-6-(3-methyl-2-butenyl)-3,4-dihydro-2H-1-benzopyran
3alpha-isobutyryloxy-5beta-(4-hydroxytigloyloxy)-7-hydroxycarvotacetone|3alpha-isobutyryloxy-5beta-<4-hydroxytigloyloxy>-7-hydroxycarvotacetone
(6E)-1-(2,4-dihydroxyphenyl)-3,7-dimethyl-3-vinyl-8-(4-methyl-2-furyl)-6-octen-1-one|1-(2,4-dihydroxyphenyl)-3,7-dimethyl-3-vinyl-8-(4-methyl-2-furyl)-6(E)-octen-1-one
1beta,3alpha-diethyloxy-7-hydroxymethyl-4-(3-methyl-butyryloxymethyl)-cyclopenta-4(4a),7(7a)-diene[c]pyran-6-one
(4E,7E)-1-(2,4-dihydroxyphenyl)-9-(4-methylfuran-2-yl)-3,4,8-trimethylnona-4,7-dien-1-one|ferulaeone D
(4S,4aS,5R,6S,8aS,9aS)-6-(acetyloxy)-4a,5,6,7,8,8a,9,9a-octahydro-8a-hydroxy-4,9a-dimethoxy-3,4a,5-trimethylnaphtho[2,3-b]furan-2(4H)-one|3beta-acetoxy-10beta-hydroxy-6beta,8beta-dimethoxyeremophil-7(11)-en-12,8alpha-olide
1-hydroxy-6,6,9-trimethyl-3-pentyl-6H-benzo[c]chromene-2-carboxylic acid methyl ester|Cannabinolinsaeure-methylester|Cannabinolsaeure-methylester
17-phenyl trinor Prostaglandin A2
C19H28O7_4H-Phenanthro[10,1-bc]furan-4-one, tetradecahydro-1,2,6,9,10-pentahydroxy-3,10a,10c-trimethyl-7-methylene-, (1S,2R,3R,5aS,6R,9S,10S,10aS,10cR)
(S,E)-2-(4,8-dimethylnona-3,7-dien-1-yl)-5-hydroxy-2-methyl-2H-chromene-7,8-dicarbaldehyde
(2S,3S,4S,8R,9S,13R,14R,15S,16R)-3,4,8,14,15-pentahydroxy-2,13,16-trimethyl-6-methylidene-10-oxatetracyclo[7.6.1.0²,?.0¹²,¹?]hexadecan-11-one
Longilactone, delta-4(18)-Isomer, 2alpha-alcoho
trans,trans-3,4,5-trifluorophenyl 4-ethylbicyclohexyl-4-carboxylate
2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride
BMS-690514
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
tert-Butyl 5-cyano-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
tert-Butyl 6-cyano-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
4,4,4,4,7,7-hexamethyl-2,2-spirobi[3H-chromene]-6,6-diol
4,4-Dihydroxy-3,3,5,5-tetramethyldiphenylmethane diglycidyl ether
2-Hydroxy-2-methyl-1-phenyl-1-propanone mixt. with (1-hydroxycyclohexyl)phenylmethanone
4-Amino-1-((4-(3-methoxyphenylamino)pyrrolo[1,2-f][1,2,4]triazin-5-yl)methyl)piperidin-3-ol
[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl](4,5,6,7-tetrahydro-2H-indazol-3-yl)methanone
3,4,8,14,15-Pentahydroxy-2,13,16-trimethyl-6-methylidene-10-oxatetracyclo[7.6.1.02,7.012,16]hexadecan-11-one
1-butyl-5-[1-[2-(1H-indol-3-yl)ethylamino]ethylidene]-1,3-diazinane-2,4,6-trione
4-[cyclohexyl(methyl)amino]-N-(6-methyl-2-pyridinyl)-3-nitrobenzamide
4-[(E)-{2-[2,6-di(pyrrolidin-1-yl)pyrimidin-4-yl]hydrazinylidene}methyl]benzene-1,2-diol
(Z)-N-[4-(9H-Fluoren-9-yl)piperazin-1-yl]-1-pyridin-4-ylethanimine
(9R,17R)-9-fluoro-6,11,16,17-tetrahydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
(1S,5R)-7-[4-[(Z)-2-phenylethenyl]phenyl]-6-(pyrimidin-5-ylmethyl)-3,6-diazabicyclo[3.1.1]heptane
(2S,3S,4S,8R,9S,13R,14R,15S,16R)-3,4,8,14,15-pentahydroxy-2,13,16-trimethyl-6-methylidene-10-oxatetracyclo[7.6.1.0(2),.0(1)(2),(1)]hexadecan-11-one
(2r,3r)-3-chloro-3,7,11-trimethyl-1-(5-nitro-1h-pyrrol-3-yl)dodeca-6,10-dien-2-ol
1,12-dihydroxy-2,11-dimethyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradecan-9-yl 2-methylpropanoate
(1r,4r,6s,8r,9s,10s,11s)-10-(acetyloxy)-6-formyl-9-isopropyl-1-methyl-5,12-dioxatricyclo[9.1.0.0⁴,⁶]dodecan-8-yl acetate
[(1r,3r)-1,3-diethoxy-7-(hydroxymethyl)-6-oxo-1h,3h,5h-cyclopenta[c]pyran-4-yl]methyl 3-methylbutanoate
1,13-dihydroxy-2,11-dimethyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradecan-9-yl 2-methylpropanoate
4-{[(1s,4r,6r,7r,8r,9r,13s)-6,9-dihydroxy-2,2,9-trimethyl-12-oxatetracyclo[6.3.2.0¹,⁴.0⁵,¹³]tridecan-7-yl]oxy}-4-oxobutanoic acid
(3as,4s,6s,10r,11s,11ar)-4,10-dihydroxy-6,10-dimethyl-3-methylidene-2,5-dioxo-octahydrocyclodeca[b]furan-11-yl 2-methylpropanoate
4-{[(1s,4r,5r,6r,7r,8r,9r,13s)-6,9-dihydroxy-2,2,9-trimethyl-12-oxatetracyclo[6.3.2.0¹,⁴.0⁵,¹³]tridecan-7-yl]oxy}-4-oxobutanoic acid
(2s)-2,5,7-trimethoxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-1-benzopyran
2α-hydroxytirotundin
{"Ingredient_id": "HBIN005297","Ingredient_name": "2\u03b1-hydroxytirotundin","Alias": "NA","Ingredient_formula": "C19H28O7","Ingredient_Smile": "CC1CC2C(C(CC3(CC(C1(O3)O)O)C)OC(=O)C(C)C)C(=C)C(=O)O2","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10768","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}